Action Euda Health - EUDA

Euda Health Holdings Ltd (EUDA) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

16,00

( -1,90% )

Prix Achat

15,86

Prix Vente

17,00

Volume échangé

5 295

16,00 Fourchette du Jour 16,32

0,3269 Plage de 52 semaines 25,70

Cap du marché

47,909M

Clôture Veille

16,31

Ouverture

16,32

Dernière Transaction

16.01

Dernière heure de transaction

Volume financier

US$ 85 089

VWAP

16,0698

Volume moyen (3 m)

US$ 118 106

Actions en circulation

2 994 325

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-12,17

Bénéfice par action (BPA)

-1,48

Chiffre d'affairess (LTM)

6,82M

Bénéfice net (LTM)

-2,77M

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. T... EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore. Show more

Secteur

Healthcare

Industrie

Healthcare Providers & Services

Site Web

eudahealth.com

Siège social

Singapore, Singapore

Fondé

Euda Health Holdings Ltd est coté dans le secteur Healthcare de la NASDAQ avec le ticker EUDA. Le dernier cours de clôture d'Euda Health était de US$16,31. Au cours de la dernière année, les actions de Euda Health ont été négociées dans une fourchette de prix de US$ 0,3269 à US$ 25,70.

Euda Health compte actuellement 2 994 325 actions en circulation. La capitalisation boursière d'Euda Health est de US$47,91 million. Euda Health a un ratio cours/bénéfice (ratio PE) de -12.17.

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the...

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”), a...

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

SINGAPORE, April 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based...

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

Singapore, April 27, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS...

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-2.66	-14.255091104	18.66	18.66	16	5691	16.77783874	CS
4	2.7	20.3007518797	13.3	18.9	13.08	12255	15.97739438	CS
12	15.502	3112.85140562	0.498	25.7	0.3269	144306	10.59438647	CS
26	13.03	438.720538721	2.97	25.7	0.3269	337522	3.73138553	CS
52	12.72	387.804878049	3.28	25.7	0.3269	215139	3.45452536	CS
156	14.53	988.43537415	1.47	25.7	0.3269	138795	2.91607578	CS
260	11.1	226.530612245	4.9	25.7	0.3269	236433	2.69273435	CS

EUDA - Frequently Asked Questions (FAQ)

What is the current Euda Health Holdings Ltd share price?

The current share price of Euda Health Holdings Ltd is US$ 16,00

How many Euda Health Holdings Ltd shares are in issue?

Euda Health Holdings Ltd has 2 994 325 shares in issue

What is the market cap of Euda Health Holdings Ltd?

The market capitalisation of Euda Health Holdings Ltd is USD 47,91M

What is the 1 year trading range for Euda Health Holdings Ltd share price?

Euda Health Holdings Ltd has traded in the range of US$ 0,3269 to US$ 25,70 during the past year

What is the PE ratio of Euda Health Holdings Ltd?

The price to earnings ratio of Euda Health Holdings Ltd is -12,17

What is the cash to sales ratio of Euda Health Holdings Ltd?

The cash to sales ratio of Euda Health Holdings Ltd is 6,66

What is the registered address of Euda Health Holdings Ltd?

The registered address for Euda Health Holdings Ltd is 60 Kaki Bukit Place, Singapore, 415979

What is the Euda Health Holdings Ltd website address?

The website address for Euda Health Holdings Ltd is eudahealth.com

Which industry sector does Euda Health Holdings Ltd operate in?

Euda Health Holdings Ltd operates in the Healthcare Providers & Services sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Euda Health Holdings Ltd (EUDA)

Euda Health Holdings Ltd (EUDA) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Euda Health Holdings Ltd

EUDA Dernières nouvelles

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

EUDA Health to Launch EUDA Helixé 2.0 in January 2026

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

EUDA - Frequently Asked Questions (FAQ)

EUDA Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités